Cryptobiotix is a preclinical CRO providing insights into the gastrointestinal tract and gut microbiome. The validated, ex vivo SIFR® technology combines unmatched throughput and predictivity for clinical outcomes. We offer research services to customers in the area of functional foods and therapeutic products, across foodtech, biotech and pharma. From early R&D screening to in-depth characterisation, we address your specific research questions and provide you with the answers to accelerate and de-risk your product development.
| Website | http://www.cryptobiotix.com |
| Employees | 23 (15 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Gastrointestinal Research, Preclinical Cro, High Throughput Screening, Gut Microbiome Analysis, Predictive Modeling, Clinical Outcomes, Drug Development Services, Clinical Trial Support, Microbiome Research, Bioavailability Studies, Preclinical Studies, Biotechnology Research, Pharmaceutical Research, Drug Metabolism, In Vitro Studies, Research Services, Gut Health |
Looking for a particular Cryptobiotix employee's phone or email?
Pieter van Den Abbeele is the CSO and Co-founder of Cryptobiotix.
15 people are employed at Cryptobiotix.